Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C‐DOT)

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|25|1|37-46

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.1, 2018-01, pp. : 37-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 790-801

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir and ribavirin use in wait‐listed patients with hepatitis C should be selective

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 7-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐induced liver injury in a chronic hepatitis C patient treated by peginterferon, ribavirin and simeprevir

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E156-E160

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy in Patients with Dose Reduction in Combination Therapy of Peginterferon and Ribavirin for Chronic Hepatitis C

By  

Intervirology, Vol. 51, Iss. 1, 2008-02 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden

By Bernfort Lars   Sennfält Karin   Reichard Olle  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 6-7, 2006-07 ,pp. : 497-505

Informa Healthcare

Access to resources Recommend Favorite